{"doc_id": "PMID-10364191.txt", "sent_id": "S1", "tokens": ["Potent", "and", "stable", "attenuation", "of", "live-HIV-1", "by", "gain", "of", "a", "proteolysis", "-", "resistant", "inhibitor", "of", "NF-kappaB", "(", "IkappaB-alpha", "S32", "/", "36A", ")", "and", "the", "implications", "for", "vaccine", "development", "."], "sentence": "Potent and stable attenuation of live-HIV-1 by gain of a proteolysis - resistant inhibitor of NF-kappaB ( IkappaB-alpha S32 / 36A ) and the implications for vaccine development .", "event_mentions": [{"id": "E1", "event_type": "Protein_catabolism", "trigger": {"text": "proteolysis", "start": 10, "end": 10}, "arguments": [{"entity_id": "T1", "text": "IkappaB-alpha", "role": "Theme"}]}], "entity_mentions": [{"id": "T1", "text": "IkappaB-alpha", "entity_type": "Protein", "start": 17, "end": 17}, {"id": "T8", "text": "proteolysis", "entity_type": "Protein_catabolism", "start": 10, "end": 10}]}
{"doc_id": "PMID-10364191.txt", "sent_id": "", "tokens": ["Live", "-", "attenuated", "human", "immunodeficiency", "viruses", "(", "HIVs", ")", "are", "candidates", "for", "Acquired", "Immunodeficiency", "Syndrome", "(", "AIDS", ")", "vaccine", "."], "sentence": "Live - attenuated human immunodeficiency viruses ( HIVs ) are candidates for Acquired Immunodeficiency Syndrome ( AIDS ) vaccine .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10364191.txt", "sent_id": "S3", "tokens": ["Based", "on", "the", "simian", "immunodeficiency", "virus", "(", "SIV", ")", "model", "for", "AIDS", ",", "loss", "-", "of-function", "(", "e.g", ".", "deletion", "of", "accessory", "genes", "such", "as", "nef", ")", "has", "been", "forwarded", "as", "a", "primary", "approach", "for", "creating", "enfeebled", ",", "but", "replication-competent", ",", "HIV-1", "/", "SIV", "."], "sentence": "Based on the simian immunodeficiency virus ( SIV ) model for AIDS , loss - of-function ( e.g . deletion of accessory genes such as nef ) has been forwarded as a primary approach for creating enfeebled , but replication-competent , HIV-1 / SIV .", "event_mentions": [], "entity_mentions": [{"id": "T2", "text": "nef", "entity_type": "Protein", "start": 25, "end": 25}]}
{"doc_id": "PMID-10364191.txt", "sent_id": "", "tokens": ["Regrettably", ",", "recent", "evidence", "suggests", "that", "loss", "-", "of-function", "alone", "is", "not", "always", "sufficient", "to", "prevent", "the", "emergence", "of", "virulent", "mutants", "."], "sentence": "Regrettably , recent evidence suggests that loss - of-function alone is not always sufficient to prevent the emergence of virulent mutants .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10364191.txt", "sent_id": "", "tokens": ["New", "strategies", "that", "attenuate", "via", "mechanisms", "distinct", "from", "loss", "-", "of-function", "are", "needed", "for", "enhancing", "the", "safety", "phenotype", "of", "viral", "genome", "."], "sentence": "New strategies that attenuate via mechanisms distinct from loss - of-function are needed for enhancing the safety phenotype of viral genome .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10364191.txt", "sent_id": "", "tokens": ["Here", ",", "we", "propose", "gain-of", "-", "function", "to", "be", "used", "simultaneously", "with", "loss", "-", "of-function", "as", "a", "novel", "approach", "for", "attenuating", "HIV-1", "."], "sentence": "Here , we propose gain-of - function to be used simultaneously with loss - of-function as a novel approach for attenuating HIV-1 .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10364191.txt", "sent_id": "S7", "tokens": ["We", "have", "constructed", "an", "HIV-1", "genome", "carrying", "the", "cDNA", "of", "a", "proteolysis", "-", "resistant", "nuclear", "factor-kappaB", "inhibitor", "(", "IkappaB-alpha", "S32", "/", "36A", ")", "in", "the", "nef", "region", "."], "sentence": "We have constructed an HIV-1 genome carrying the cDNA of a proteolysis - resistant nuclear factor-kappaB inhibitor ( IkappaB-alpha S32 / 36A ) in the nef region .", "event_mentions": [{"id": "E2", "event_type": "Protein_catabolism", "trigger": {"text": "proteolysis", "start": 11, "end": 11}, "arguments": [{"entity_id": "T3", "text": "IkappaB-alpha", "role": "Theme"}]}, {"id": "E3", "event_type": "Negative_regulation", "trigger": {"text": "resistant", "start": 13, "end": 13}, "arguments": [{"entity_id": "T9", "text": "proteolysis", "role": "Theme"}]}], "entity_mentions": [{"id": "T3", "text": "IkappaB-alpha", "entity_type": "Protein", "start": 18, "end": 18}, {"id": "T4", "text": "nef", "entity_type": "Protein", "start": 25, "end": 25}, {"id": "T9", "text": "proteolysis", "entity_type": "Protein_catabolism", "start": 11, "end": 11}, {"id": "T10", "text": "resistant", "entity_type": "Negative_regulation", "start": 13, "end": 13}]}
{"doc_id": "PMID-10364191.txt", "sent_id": "S8", "tokens": ["HIV-1", "expressing", "IkappaB-alpha", "S32", "/", "36A", "down-regulates", "viral", "expression", "and", "is", "highly", "attenuated", "in", "both", "Jurkat", "and", "peripheral", "blood", "mononuclear", "cells", "."], "sentence": "HIV-1 expressing IkappaB-alpha S32 / 36A down-regulates viral expression and is highly attenuated in both Jurkat and peripheral blood mononuclear cells .", "event_mentions": [{"id": "E4", "event_type": "Gene_expression", "trigger": {"text": "expressing", "start": 1, "end": 1}, "arguments": [{"entity_id": "T5", "text": "IkappaB-alpha", "role": "Theme"}]}, {"id": "E5", "event_type": "Negative_regulation", "trigger": {"text": "attenuated", "start": 12, "end": 12}, "arguments": [{"entity_id": "T11", "text": "expressing", "role": "Theme"}]}], "entity_mentions": [{"id": "T5", "text": "IkappaB-alpha", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T11", "text": "expressing", "entity_type": "Gene_expression", "start": 1, "end": 1}, {"id": "T12", "text": "attenuated", "entity_type": "Negative_regulation", "start": 12, "end": 12}]}
{"doc_id": "PMID-10364191.txt", "sent_id": "S9", "tokens": ["We", "provide", "formal", "proof", "that", "the", "phenotypic", "and", "attenuating", "characteristics", "of", "IkappaB-alpha", "S32", "/", "36A", "permit", "its", "stable", "maintenance", "in", "a", "live", ",", "replicating", "HIV-1", "despite", "180", "days", "of", "forced", "ex", "vivo", "passaging", "in", "tissue", "culture", "."], "sentence": "We provide formal proof that the phenotypic and attenuating characteristics of IkappaB-alpha S32 / 36A permit its stable maintenance in a live , replicating HIV-1 despite 180 days of forced ex vivo passaging in tissue culture .", "event_mentions": [{"id": "E6", "event_type": "Positive_regulation", "trigger": {"text": "maintenance", "start": 18, "end": 18}, "arguments": [{"entity_id": "T6", "text": "IkappaB-alpha", "role": "Theme"}]}], "entity_mentions": [{"id": "T6", "text": "IkappaB-alpha", "entity_type": "Protein", "start": 11, "end": 11}, {"id": "T13", "text": "maintenance", "entity_type": "Positive_regulation", "start": 18, "end": 18}]}
{"doc_id": "PMID-10364191.txt", "sent_id": "", "tokens": ["As", "compared", "with", "other", "open-reading", "frames", "embedded", "into", "HIV", "/", "SIV", "genome", ",", "this", "degree", "of", "stability", "is", "unprecedented", "."], "sentence": "As compared with other open-reading frames embedded into HIV / SIV genome , this degree of stability is unprecedented .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10364191.txt", "sent_id": "S11", "tokens": ["Thus", ",", "IkappaB-alpha", "S32", "/", "36A", "offers", "proof-of-principle", "that", "artifactually", "gained", "functions", ",", "when", "used", "to", "attenuate", "the", "replication", "of", "live", "HIV-1", ",", "can", "be", "stable", "."], "sentence": "Thus , IkappaB-alpha S32 / 36A offers proof-of-principle that artifactually gained functions , when used to attenuate the replication of live HIV-1 , can be stable .", "event_mentions": [], "entity_mentions": [{"id": "T7", "text": "IkappaB-alpha", "entity_type": "Protein", "start": 2, "end": 2}]}
{"doc_id": "PMID-10364191.txt", "sent_id": "", "tokens": ["These", "findings", "illustrate", "gain-of", "-", "function", "as", "a", "feasible", "strategy", "for", "developing", "safer", "live", "-", "attenuated", "HIVs", "to", "be", "tested", "as", "candidates", "for", "AIDS", "vaccine", "."], "sentence": "These findings illustrate gain-of - function as a feasible strategy for developing safer live - attenuated HIVs to be tested as candidates for AIDS vaccine .", "event_mentions": [], "entity_mentions": []}
